Access Bio gets FDA emergency authorization for quick Covid-19 test

Access Bio gets FDA emergency authorization for quick Covid-19 test

Source: 
MedCity News
snippet: 

The company said the CareStart Covid-19 MDx RT-PCR test is designed to detect RNA from the SARS-CoV-2 virus and produce results within 83 minutes.